Professor Alan Boyd is a highly regarded pharmaceutical physician with expertise across all phases of drug development.
Following a career as a senior executive in major pharmaceutical companies he was appointed Head of Research and Development at Ark Therapeutics and was instrumental in their growth to become an established healthcare company.
He also had a key role in raising funds for the business in the form of venture capital and during the IPO process.
By combining expertise across a wide variety of therapeutic areas with in-depth knowledge of the investment community’s requirements, he is ideally placed to support our sponsors in planning and implementing their clinical development programmes.
Professor Boyd was elected President of the Faculty of Pharmaceutical Medicine in November 2015.